Drug Profile
Research programme: PET/CT imaging agents - J-Pharma
Alternative Names: JPH-223Latest Information Update: 18 Sep 2023
Price :
$50
*
At a glance
- Originator J-Pharma
- Class Imaging agents
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Unspecified
Most Recent Events
- 18 Sep 2023 Discontinued - Preclinical for Unspecified (Diagnosis) in Japan (unspecified route) (J-Pharma pipeline, September 2023)
- 28 Oct 2020 No recent reports of development identified for preclinical development in Unspecified(Diagnosis) in Japan
- 19 Sep 2016 Preclinical trials in Undefined indication in Japan (unspecified route)